Novavax's total assets for Q3 2024 were $1.71B, a decrease of -5.84% from the previous quarter. NVAX total liabilities were $2.24B for the fiscal quarter, a -0.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.